TransMedics Group, Inc.

General ticker "TMDX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $3.7B (TTM average)

TransMedics Group, Inc. does not follow the US Stock Market performance with the rate: -9.7%.

Estimated limits based on current volatility of 3.6%: low 83.77$, high 89.98$

Factors to consider:

  • Earnings expected soon, date: 2025-04-29 bmo
  • Current price 23.8% above estimated high

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [29.37$, 71.26$]
  • 2025-12-31 to 2026-12-31 estimated range: [25.83$, 61.62$]

Financial Metrics affecting the TMDX estimates:

  • Positive: 0.87 < Non-GAAP EPS, $ of 1.01
  • Positive: 2.69 < Return on assets ratio (scaled to [-100,100]) of 4.22
  • Positive: Industry inventory ratio change (median), % of -0.37 <= -0.28
  • Positive: 8.37 < Operating profit margin, % of 8.49
  • Positive: 1.79 < Operating cash flow per share per price, % of 2.12
  • Negative: Industry operating cash flow per share per price (median), % of -3.23 <= 2.82
  • Positive: 22.52 < Shareholder equity ratio, % of 28.43 <= 43.26
  • Negative: Investing cash flow per share, $ of -3.89 <= -3.20

Similar symbols

Short-term TMDX quotes

2025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-112025-04-142025-04-152025-04-162025-04-176570758085
Price $

Long-term TMDX plot with estimates

20406080100120140160180Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 2027−0.200.2
TMDXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $93.46MM $241.62MM $441.54MM
Operating Expenses $124.90MM $270.35MM $404.04MM
Operating Income $-31.44MM $-28.73MM $37.50MM
Non-Operating Income $-4.73MM $2.06MM $-1.72MM
Interest Expense $3.73MM $10.79MM $14.41MM
R&D Expense $26.81MM $63.27MM $55.97MM
Income(Loss) $-36.16MM $-26.67MM $35.78MM
Taxes $0.07MM $-1.64MM $0.32MM
Profit(Loss)* $-36.23MM $-25.03MM $70.93MM
Stockholders Equity $187.38MM $137.20MM $228.60MM
Inventory $20.61MM $44.23MM $46.55MM
Assets $277.15MM $706.05MM $804.08MM
Operating Cash Flow $-45.82MM $-13.03MM $48.80MM
Capital expenditure $11.91MM $179.06MM $0.00MM
Investing Cash Flow $54.51MM $-193.95MM $-129.30MM
Financing Cash Flow $167.93MM $400.42MM $22.87MM
Earnings Per Share** $-1.23 $-0.77 $2.13

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.